Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL

Clinical trial NCT04685915 · WITHDRAWN

Trial details

NCT number: NCT04685915
Sponsor: Inhye Ahn
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)

Start date: 2021-02-18
Primary completion: 2023-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.